Vir Biotechnology Inc (NQ: VIR )
8.260
-0.040
(-0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Vir Biotechnology Inc
![](https://cdn.benzinga.com/files/images/story/2022/11/07/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20776.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/image-yelp.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/04/aapharma_9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image_2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/707951/rising-stock-charts.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6984.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-VirBiotechnology-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/image40.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/20/covid-19_corona-5174671_1920__image_by_gerd_altmann_from_pixabay_.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/14/aapharma_13.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/10/aapharma_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9408.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/19/aapharma_5.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/16/who_and_roche_covid-19_miguel_a._padrinan_by_pexels_and_wikipedia.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/02/white_house_dc.jpg?width=1200&height=800&fit=crop)
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_3422.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/15/insulin_towfiqu-barbhuiya-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26295.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/10/biotech11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14429.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/biotech7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4492.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8210.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4297.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.